封面
市場調查報告書
商品編碼
1618147

2024 - 2032 年卵子冷凍和胚胎銀行市場機會、成長動力、產業趨勢分析和預測

Egg Freezing and Embryo Banking Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年,全球卵子冷凍和胚胎銀行市場估值為43 億美元,預計2024 年至2032 年複合年成長率將達到9.8%。女性的卵子。這種方法使女性能夠保護自己的生育能力,使她們能夠靈活地在以後懷孕。另一方面,胚胎庫需要創建和保存胚胎以供未來應用。這個過程通常需要在實驗室中用精子使女性的卵子受精,然後冷凍產生的胚胎以供以後植入。

整個卵子冷凍和胚胎庫產業根據服務類型、技術、應用、儲存時間、年齡層和地區進行分類。卵子冷凍和胚胎銀行市場依服務類型分為卵子冷凍和胚胎銀行。 2023年,胚胎銀行業務引領市場,創造了27億美元的可觀收入。這種現代方法與不斷變化的生活方式和延遲生育的趨勢產生了共鳴,使個人能夠保護自己的生育潛力。

隨著社會接受度和意識的提高,對這些服務的需求也在成長。人類受精與胚胎學管理局的 2023 年報告強調,與 2019 年的數據相比,2020 年英國胚胎儲存週期將增加 6.87%,2021 年將顯著增加 17.18%。到 2023 年,長期儲存領域的價值將達到 25 億美元,成為市場的主導者。社會和文化觀點的轉變,對不同計劃生育途徑的認知,再加上保險公司和雇主對生育力保存福利的支持不斷增加,正在支撐卵子冷凍和胚胎銀行市場的長期儲存領域。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 43億美元
預測值 99 億美元
複合年成長率 9.8%

此外,對這些服務的需求顯著增加,特別是在癌症患者中,建議考慮卵子冷凍或胚胎庫作為治療潛在的生育能力損害的保護措施。 2023年,美國引領北美市場,營收達17億美元。在美國和加拿大,一個明顯的趨勢是女性出於職業發展、高等教育和個人選擇等原因而推遲生育。這極大地推動了該地區的市場成長,因為許多女性現在將生育力保存視為協調其職業和個人願望的策略性舉措。 ,減輕了個人的經濟負擔,提高了該地區獲得這些程序的機會。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 女性和夫婦對保留生育能力的認知和接受度不斷提高
      • 冷凍保存技術的進步
      • 全球不孕率上升
    • 產業陷阱與挑戰
      • 卵子冷凍和胚胎儲存成本高
      • 圍繞著冷凍卵子和胚胎的使用和處置的道德和法律問題
  • 成長潛力分析
  • 卵子冷凍和胚胎儲存週期的程序量,2021-2032
  • 每個週期的全球成本分析,2023 年
  • 報銷場景
  • 監管環境
  • 技術景觀
  • 未來市場趨勢
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 介紹
  • 公司市佔率分析
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按服務類型,2021 - 2032 年

  • 主要趨勢
  • 卵子冷凍
  • 胚胎銀行

第 6 章:市場估計與預測:按儲存時間分類,2021 年至 2032 年

  • 主要趨勢
  • 短期儲存
  • 長期儲存

第 7 章:市場估計與預測:按技術分類,2021 - 2032

  • 主要趨勢
  • 玻璃化冷凍
  • 慢速冷凍

第 8 章:市場估計與預測:按應用分類,2021 - 2032

  • 主要趨勢
  • 生育力保存
  • 捐贈卵子/胚胎計劃
  • 基因篩檢
  • 腫瘤生育力

第 9 章:市場估計與預測:按年齡分類,2021 - 2032

  • 主要趨勢
  • 30歲以下
  • 31 至 40
  • 41歲以上

第 10 章:市場估計與預測:按地區分類,2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:公司簡介

  • Boston IVF
  • Carrot
  • CCRM Fertility
  • Cryos International
  • Extend Fertility
  • Genea Pty
  • IVIRMA
  • Monash IVF Group
  • New Hope IVF & Fertility Clinic
  • Ovation Fertility
  • Progyny
  • ReproTech
  • RMA Network
  • Shady Grove Fertility
  • Spring Fertility
  • WINFertility
簡介目錄
Product Code: 11172

The Global Egg Freezing and Embryo Banking Market was valued at USD 4.3 billion in 2023 and is projected to indicate a robust CAGR of 9.8% from 2024 to 2032. oocyte cryopreservation, also known as Egg freezing, involves freezing, extracting, and storing a woman's eggs (oocytes) for potential future use. This method empowers women to safeguard their fertility, granting them the flexibility to conceive at a later date. On the other hand, embryo banking entails creating and preserving embryos for future applications. This process usually entails fertilizing a woman's eggs with sperm in a lab, subsequently freezing the resulting embryos for later implantation.

The overall egg freezing and embryo banking industry is classified based on service type, technology, application, storage duration, age group, and region. The egg freezing and embryo banking market is segmented by service type into egg freezing and embryo banking. In 2023, the embryo banking segment led the market, generating a substantial revenue of USD 2.7 billion. This modern approach resonates with changing lifestyles and the trend of delayed parenthood, allowing individuals to safeguard their fertility potential.

As societal acceptance and awareness grow, so does the demand for these services. The Human Fertilization & Embryology Authority's 2023 report highlights a 6.87% rise in embryo storage cycles in the UK for 2020 and a notable 17.18% surge in 2021, both compared to 2019 figures. The long-term storage segment, valued at USD 2.5 billion in 2023, emerged as the dominant player in the market. Shifts in societal and cultural perspectives, recognizing diverse family planning avenues, coupled with increasing backing from insurance firms and employers for fertility preservation benefits, are bolstering the long-term storage segment of the egg freezing and embryo banking market.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$4.3 Billion
Forecast Value$9.9 Billion
CAGR9.8%

Moreover, there's a notable uptick in demand for these services, especially among cancer patients advised to consider egg freezing or embryo banking as a protective measure against potential fertility impairment from treatments. In 2023, the U.S. led the North American market, raking in a revenue of USD 1.7 billion. In the U.S. and Canada, a pronounced trend sees women postponing childbirth for reasons like career progression, advanced education, and personal choices. This has significantly fueled the region's market growth, as many women now view fertility preservation as a strategic move to harmonize their professional and personal aspirations.Furthermore, the financial backing from insurance entities and employers, who are progressively incorporating fertility preservation coverage in health plans, has alleviated the financial burden on individuals, enhancing accessibility to these procedures in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing awareness and acceptance of fertility preservation options among women and couples
      • 3.2.1.2 Advancements in cryopreservation techniques
      • 3.2.1.3 Rising global infertility rates
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of egg freezing and embryo banking
      • 3.2.2.2 Ethical and legal issues surrounding the use and disposition of frozen eggs and embryos
  • 3.3 Growth potential analysis
  • 3.4 Procedure volume of egg freezing and embryo banking cycles, 2021-2032
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 Asia Pacific
    • 3.4.4 Latin America
    • 3.4.5 Middle East and Africa
  • 3.5 Global cost analysis per cycle, 2023
  • 3.6 Reimbursement scenario
  • 3.7 Regulatory landscape
  • 3.8 Technological landscape
  • 3.9 Future market trends
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Service Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Egg freezing
  • 5.3 Embryo banking

Chapter 6 Market Estimates and Forecast, By Storage Duration, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Short-term storage
  • 6.3 Long-term storage

Chapter 7 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Vitrification
  • 7.3 Slow freezing

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Fertility preservation
  • 8.3 Donor egg/embryo programs
  • 8.4 Genetic screening
  • 8.5 Oncofertility

Chapter 9 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Under 30
  • 9.3 31 to 40
  • 9.4 Over 41

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 Boston IVF
  • 11.2 Carrot
  • 11.3 CCRM Fertility
  • 11.4 Cryos International
  • 11.5 Extend Fertility
  • 11.6 Genea Pty
  • 11.7 IVIRMA
  • 11.8 Monash IVF Group
  • 11.9 New Hope IVF & Fertility Clinic
  • 11.10 Ovation Fertility
  • 11.11 Progyny
  • 11.12 ReproTech
  • 11.13 RMA Network
  • 11.14 Shady Grove Fertility
  • 11.15 Spring Fertility
  • 11.16 WINFertility